Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Clinical Outcome in Patients With Spinal Dural Arteriovenous Fistulas (COPSDAVF)

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
Staatus
Sponsorid
Hongqi Zhang, MD
Kaastöötajad
Beijing Haidian Hospital

Märksõnad

Abstraktne

Spinal dural arteriovenous fistulas (SDAVFs) are the most common vascular disorder of the spine and account for approximately 70% of spinal vascular malformation.They are a rare pathology with an excepted incidence of only 5-10 new cases per million inhabitants per year. Most fistulas are found in the thoracolumbar region and > 80% of all SDAVFs are located between T6 and L2, whereas the cranio-cervical, cervical and sacral fistulas are more rare. SDAVFs have an overwhelmingly male predominance (80%), with an age presentation in the fifth or sixth dacede. It is presumed that SDAVFs are acquired diseases. A typical SDAVF is located inside the dural mater close to nerve root. It is fed by a radiculomeningeal artery and enters a radicular vein that merges in the perimedullary plexus. The presence of a shunt leads to a reversal of blood flow to the spinal cord venous system, which then induces venous hypertensive myelopathy.

Kirjeldus

The initial symptoms of venous congestion include gait disturbances, sensory symptoms (hyperesthesia and paresthesia), and sphincter dysfunction. These neurological symptoms are unspecific, so SDAVFs often go clinically underdiagnosed or misdiagnosed. But SDAVFs typically demonstrated a characteristic imaging appearance on spinal MRI including multilevel centromedullary cord T2 hyperintensity, enlarged intradural vessels along the dorsal and ventral aspect of the cord. If an SDAVF is suspected, conventional spinal angiography is required to confirm the diagnosis and determine the location of the fistula. Flowing diagnosis, expedient treatment is required, both microsurgery and endovascular embolization are safe and can achieve complete occlusion, the progression of the neurological deficits can be stopped in most instances.

However, it is difficult to predict whose symptoms will improve and whose will stabilize or deteriorate. Due to the low incidence of the SDAVFs, nearly all studies which have been published about the clinical outcome and prognostic factors of SDAVFs are relatively limited and most of them are retrospective. In these studies, the preoperative severity of disability, age, gender, location of fistula and duration of symptoms have been analyzed as prognostic factors, therefore it remains unclear which are the most reliable predictor of clinical outcome. Moreover, the conclusions may be biased by long span of follow-up period or few clinical cases. Besides, the fitulas at the craniocervical junction often present with hemorrhage, while those below conus constitute 3 types of lesions. So the invsetigator conduct this prospective cohort study to clarify the 1-year outcome of patients with cervical and thoracolumbar SDAVFs and to determine the main prognostic factors.

Kuupäevad

Viimati kinnitatud: 03/31/2018
Esmalt esitatud: 06/13/2017
Hinnanguline registreerumine on esitatud: 06/17/2017
Esmalt postitatud: 06/19/2017
Viimane värskendus on esitatud: 04/18/2018
Viimati värskendus postitatud: 04/22/2018
Õppe tegelik alguskuupäev: 02/28/2013
Eeldatav esmane lõpetamise kuupäev: 03/30/2018
Eeldatav uuringu lõpetamise kuupäev: 03/30/2019

Seisund või haigus

Spinal Vascular Disorder Nos

Faas

-

Abikõlblikkuse kriteeriumid

Uuringuks kõlblikud soodAll
ProovivõtumeetodNon-Probability Sample
Võtab vastu tervislikke vabatahtlikkeJah
Kriteeriumid

Inclusion Criteria:

- patient diagnosed with spinal dural arteriovenous fiatulas

- the fiatula locate between C2 and L5

- patient not received surgical or interventional treatment before

- patient with normal cardiac, renal and hepatic function

- patient capable of understanding the content of the patient information / Informed Consent Form

- patient willing and able to participate in the registry

Exclusion Criteria:

- patient received surgical treatment or interventional treatment before

- patient is pregnant patient allergic to iodine

- patient unable to complete follow-up

- patient with cerebral lesions patient with other spinal lesions

- patient with cardiac, renal or hepatic dysfunction

Tulemus

Esmased tulemusnäitajad

1. Change of the spinal cord function [1 day before operation and 3 months, 6 months, 12 months postoperation]

Modified Aminoff & Logue's Scale for evaluating the spinal cord function

Sekundaarsed tulemusmõõdud

1. Modified Denis Pain and Numbness Scale (mDPNS) [1 day before operation and 3 months, 6 months, 12 months postoperation]

mDPNS for evaluating the sensory function of patients with SDAVFs before and after operations

Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge